BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8538821)

  • 1. Reversibility of left ventricular hypertrophy by antihypertensive drugs.
    Fagard RH
    Neth J Med; 1995 Oct; 47(4):173-9. PubMed ID: 8538821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996).
    Schmieder RE; Schlaich MP; Klingbeil AU; Martus P
    Nephrol Dial Transplant; 1998 Mar; 13(3):564-9. PubMed ID: 9550628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies.
    Schmieder RE; Martus P; Klingbeil A
    JAMA; 1996 May; 275(19):1507-13. PubMed ID: 8622227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanical and other factors relating to left ventricular hypertrophy.
    Fagard R; Lijnen P; Staessen J; Thijs L; Amery A
    Blood Press Suppl; 1994; 1():5-10. PubMed ID: 8205300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of therapeutic studies on regression of left ventricular hypertrophy.
    Schmieder RE; Schlaich MP
    Adv Exp Med Biol; 1997; 432():191-8. PubMed ID: 9433526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension.
    Klingbeil AU; Schneider M; Martus P; Messerli FH; Schmieder RE
    Am J Med; 2003 Jul; 115(1):41-6. PubMed ID: 12867233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydropyridines versus other agents in the treatment of hypertension in the elderly. Part 1: Antihypertensive therapy and left ventricular hypertrophy.
    Fagard R; Staessen J; Thijs L; Van Hoof R; Amery A
    J Hypertens Suppl; 1993 Dec; 11(6):S27-9. PubMed ID: 7909547
    [No Abstract]   [Full Text] [Related]  

  • 8. Regression of left ventricular hypertrophy--are there differences between antihypertensive agents?
    Dahlöf B
    Cardiology; 1992; 81(4-5):307-15. PubMed ID: 1363788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies.
    Fagard RH; Celis H; Thijs L; Wouters S
    Hypertension; 2009 Nov; 54(5):1084-91. PubMed ID: 19770405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy for hypertension associated with heart failure].
    Miyamoto H; Imaizumi T
    Nihon Naika Gakkai Zasshi; 2003 Feb; 92(2):258-63. PubMed ID: 12652730
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in left ventricular geometry during antihypertensive treatment.
    Salvetti M; Paini A; Bertacchini F; Stassaldi D; Aggiusti C; Agabiti Rosei C; Bassetti D; Agabiti-Rosei E; Muiesan ML
    Pharmacol Res; 2018 Aug; 134():193-199. PubMed ID: 29959031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of lisinopril vs hydralazine on left ventricular hypertrophy and ambulatory blood pressure monitoring in essential hypertension.
    Fogari R; Zoppi A; Mugellini A; Tettamanti F; Lusardi P; Corradi L
    Eur Heart J; 1995 Aug; 16(8):1120-5. PubMed ID: 8665975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Left Ventricular Hypertrophy in Hypertension. Part III. Reversibility of Left Ventricular Hypertrophy During Treatment With Antihypertensive Drugs].
    Preobrazhenskiĭ DV; Sidorenko BA; Alekhin MN; Batyraliev TA; Stetsenko TM
    Kardiologiia; 2004; 44(4):89-94. PubMed ID: 15111978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
    Gottdiener JS; Reda DJ; Massie BM; Materson BJ; Williams DW; Anderson RJ
    Circulation; 1997 Apr; 95(8):2007-14. PubMed ID: 9133508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current drug treatment and treatment patterns with antihypertensive drugs.
    Freis ED; Papademetriou V
    Drugs; 1996 Jul; 52(1):1-16. PubMed ID: 8799681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of hypertensive patients with cardiovascular damage].
    Tomiyama H; Takata Y; Yamashina A
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():612-6. PubMed ID: 15171444
    [No Abstract]   [Full Text] [Related]  

  • 17. Longitudinal change in left ventricular hypertrophy in the elderly on antihypertensive therapy.
    Ahmad A; Nawaz HM; Nevins L; Nawaz H
    Conn Med; 2003 Feb; 67(2):67-73. PubMed ID: 12664833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of left ventricular hypertrophy--a meta-analysis.
    Dahlöf B; Pennert K; Hansson L
    Clin Exp Hypertens A; 1992; 14(1-2):173-80. PubMed ID: 1347256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension and the heart.
    Schmieder RE; Messerli FH
    J Hum Hypertens; 2000; 14(10-11):597-604. PubMed ID: 11095153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.